Radiotheranostics - A Primer for Medical Physicists I

Radiotheranostics - A Primer for Medical Physicists I
-0 %
Physics, Chemistry, Biology and Clinical Applications
Besorgungstitel - wird vorgemerkt | Lieferzeit: Besorgungstitel - Lieferbar innerhalb von 10 Werktagen I

Unser bisheriger Preis:ORGPRICE: 212,50 €

Jetzt 212,48 €*

Alle Preise inkl. MwSt. | Versandkostenfrei
Artikel-Nr:
9781032138978
Veröffentl:
2024
Erscheinungsdatum:
20.02.2024
Seiten:
214
Autor:
Cari Borras
Gewicht:
590 g
Format:
254x178x0 mm
Sprache:
Deutsch
Beschreibung:

Cari (Caridad) Borrás is a certified medical physicist in Washington, DC, USA, where she works as an international consultant and has an adjunct faculty position at the George Washington University School of Medicine and Health Sciences. She obtained a Doctor of Science (Physics) degree from the University of Barcelona, Spain, having done a thesis research project on the dosimetry and embryological effects of Astatine- 211 at Thomas Jefferson University in Philadelphia, PA, USA, as a Fulbright scholar. She has lectured in more than 300 seminars/courses/congresses, many organized by her; authored/contributed around 100 articles and six book chapters and edited two books. She is a Fellow of ACR, AAPM, IOMP, HPS, and IUPESM, and has received awards/recognitions from SEFM, AAPM, IOMP, ALFIM, ACCE, ACR, and ABR.
This book covers scientific, clinical, and educational aspects of radiotheranostics in cancer control. Setting the framework, the first volume defines radiotheranostics and describes the history of radionuclide therapy and theranostics, and the biology of cancer.
Section I: Introduction. Chapter 1: What is radiotheranostics? Chapter 2: History of radionuclide therapy and theranostics. Chapter 3: Biological principles behind targeted radionuclide therapy for cancer. Section II: Clinical Applications of Targeted Radionuclide Therapy in Cancer Control. Chapter 4: Unconjugated radionuclides. Chapter 5: Radionuclide-conjugated cancer-specific vectors: Peptides. Chapter 6: Radionuclide-conjugated cancer-specific vectors: Small Molecules and antibodies. Chapter 7: Radionuclide-conjugated cancer-specific vectors: Nanoparticles. Chapter 8: Introduction to clinical trials and drug development for radionuclide therapies. Chapter 9: Epidemiologic Studies of Cancer Risk among Patients Administered Radionuclides. Chapter 10: Adverse effects of radionuclide therapy. Section III: Radiation Chemistry and Physics. Chapter 11: Radionuclide production. Chapter 12: Radioactivity measurement and traceability. Chapter 13: Instrumentation, calibration, quantitative imaging, and quality control. Section IV: The Future. Chapter 14: Human resources: Multidisciplinary team education, training, and competence. Chapter 15: Theranostics today: Looking backwards to tomorrow.

Kunden Rezensionen

Zu diesem Artikel ist noch keine Rezension vorhanden.
Helfen sie anderen Besuchern und verfassen Sie selbst eine Rezension.